Afuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1
Laekna Limited
Laekna Limited
Hospices Civils de Lyon
Incyte Corporation
Incyte Corporation
PharmaMar
Esperas Pharma Inc.
Mundipharma Research Limited
Compugen Ltd
Centre de recherche du Centre hospitalier universitaire de Sherbrooke
NextCure, Inc.
Genmab
Ability Pharmaceuticals SL
Incyte Corporation
Incyte Corporation
Seagen Inc.
Gilead Sciences
Novartis
Seagen Inc.
Lumos Pharma
San Antonio Military Medical Center
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
AGO Study Group